Thu, Aug 21, 2014, 10:59 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Impax Laboratories Inc. Message Board

  • secrtztn secrtztn Aug 17, 2010 7:51 AM Flag

    IPXL - Long Term Prospects

    You need to give the company a little time. There is a lot on the horizon, and the Company has demonstrated competency.

    1. Considerable cash balance.
    2. W/o Cash, trades at 8X earnings
    3. Management looking at an accretive acquisition. I'd expect $100M to $150M of EBITDA.
    4. Expect Adderall XR Sales increases
    5. Company is the first to file on Concerta. JNJ's patent was invalidated.
    6. Detrol LA - settlement is likely.
    7. IPX066 - considerable earnings potential down the road.
    8. Manufacturing in Taiwan - costs driven down/tax savings.
    8. Pipeline - Doryx 150 mg, Renvela, Effexor XR, Solodyn, Renagel, Amrix, Trilipix, Welchol, Fenoglide, Oracea, Tricor, Cymbalta

    Stayed tuned throughout 2011. A LOT on the Horizon.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IPXL
24.45+0.15(+0.62%)Aug 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.